Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH
When will AI replace your radiologist? What can pharma learn from ketamine? And is liver disease more complicated than anyone thought?
14 Feb 201923min
Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?
Are we underestimating biology? Will Hot 97 decide the presidency? And who owns the scientific means of production?
7 Feb 201926min
Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns
Is the drug industry wrong about Alzheimer's disease? Can cryptocurrency fund actual science? And should you feel sorry for Big Pharma?
31 Jan 201924min
Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics
Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog?
24 Jan 201924min
Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics
Is the FDA going broke? Can video games be drugs? And when did "Flashdance" come out?
17 Jan 201923min
Episode 43: A people's history of J.P. Morgan
Do drug developers tip well? Is biotech safe for 6-year-olds? And what's a Cable Car Cosmo?
10 Jan 201914min
Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
Are megamergers bad for business? Is it time for biotech's biggest gathering to find a new home? And can a "need" be anything but "unmet"?
3 Jan 201922min
Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta
What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?
20 Dec 201826min
